Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation.
Emma SandgrenCecilia RorsmanNils EdvardssonJohan EngdahlPublished in: PloS one (2018)
The stroke risk in our study population with an incident silent AF diagnosis may have been significantly decreased by the high proportion of anticoagulation treatment. This could imply that without this treatment the stroke risk might have been high enough to justify anticoagulation. Development of vascular dementia was twice as common among patients with known AF as compared to those witht silent AF or no AF. More data is needed to inform the optimal treatment for these patients.
Keyphrases
- atrial fibrillation
- left atrial
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- venous thromboembolism
- type diabetes
- cardiovascular disease
- chronic kidney disease
- percutaneous coronary intervention
- brain injury
- acute coronary syndrome
- patient reported outcomes
- replacement therapy
- blood brain barrier
- cerebral ischemia
- data analysis
- breast cancer risk
- vena cava